The European Medicines Agency and the Dutch authorities have agreed a joint governance structure to guide and oversee the agency’s move from London as a result of Brexit, with the aim of effecting a smooth relocation of the agency’s activities to its new home in Amsterdam by March 30, 2019.
As part of the relocation process, a Dutch delegation traveled to London to present the EMA’s management board’s December meeting...